ResApp to develop consumer respiratory app, to go live with Phenix app

ASX listed digital health company ResApp has signed a memorandum of understanding with health products manufacturer RB, formerly known as Reckitt Benckiser, to develop a smartphone app for consumers that uses ResApp’s cough-based algorithms to identify different respiratory conditions.

ResApp and RB have agreed to work together to build and test a prototype app for consumers to self-assess, or assess with the assistance of a pharmacist, their respiratory symptoms.

Posted in Australian eHealth

Tags: ResApp Health, Phenix Health

Comments  

0 # Anton Cush 2020-06-23 10:15
Great to be part of this progressive step to diagnose respiratory illnesses in a new way for in-clinic and telehealth use cases.
Reply

Add comment

Please note comments of a self-promotional nature are likely to be deleted.

Security code
Refresh

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2020 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.